CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT

This adverse event was reported 697 times

These drugs are most commonly taken by patients reporting CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT:

# Drug Count
0 RITUXIMAB 435
1 FLUDARABINE PHOSPHATE 237
2 VENETOCLAX 211
3 IBRUTINIB 122
4 CYCLOPHOSPHAMIDE 115
5 CYCLOPHOSPHAMIDE FOR INJECTION 115
6 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 115
7 OBINUTUZUMAB 84
8 BENDAMUSTINE HCL 61
9 IDELALISIB 54
See all common drugs associated with CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT

CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PIRTOBRUTINIB 12 0.0122
1 CHLORAMBUCIL 33 0.0084
2 IDELALISIB 54 0.0077
3 FLUDARABINE PHOSPHATE 237 0.0059
4 PENTOSTATIN 6 0.0057
5 OBINUTUZUMAB 84 0.0050
6 BENDAMUSTINE HCL 61 0.0039
7 RASBURICASE 9 0.0036
8 VENETOCLAX 211 0.0034
9 ACALABRUTINIB 36 0.0028
See all drugs enriched for association with CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT

CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 211 0.0034
1 CD20-directed Cytolytic Antibody [EPC] 478 0.0015
2 CD52-directed Cytolytic Antibody [EPC] 22 0.0011
3 Alkylating Drug [EPC] 134 0.0005
4 Thrombopoietin Receptor Agonist [EPC] 8 0.0005
5 Human Immunoglobulin G [EPC] 10 0.0005
6 alpha-Hydroxy Acid [EPC] 1 0.0005
7 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
8 Provitamin D2 Compound [EPC] 12 0.0004
9 Kinase Inhibitor [EPC] 192 0.0003
See all drug classes enriched for association with CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT